Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1342, 2002-01, pp. : 20-20
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
FDA continues review of drospirenone-containing OCs
Reactions Weekly, Vol. 1, Iss. 1371, 2011-01 ,pp. :
Access to resources
Recommend
Clinical trial registration: the debate continues . . .
Inpharma, Vol. 1, Iss. 1539, 2006-01 ,pp. :
Celecoxib and cardiovascular risks
Expert Opinion on Drug Safety, Vol. 4, Iss. 6, 2005-11 ,pp. :
Long-term safety of drug eluting stents: the debate continues
Reactions Weekly, Vol. 1, Iss. 1122, 2006-01 ,pp. :